Home Newsletters Cell Therapy News Characterization of Neoantigen-Specific T Cells in Cancer Resistant to Immune Checkpoint Therapies

Characterization of Neoantigen-Specific T Cells in Cancer Resistant to Immune Checkpoint Therapies

0
Leveraging the use of mass cytometry combined with multiplex major histocompatibility complex class I tetramer staining, researchers screened and identified tumor neoantigen–specific CD8+ T cells in the Lewis Lung carcinoma tumor model.
[Proceedings of the National Academy of Sciences of the United States of America]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version